Home The Word Brain My Amedeo FAQ Privacy About   


Explore this week’s CC Journal Club

90‑sec video • 4‑min audio • paper abstracts

This week, 27 April 2025:

  1. Treatment-resistant hypertension
  2. Influenza transmission
  3. Nanoplastics in human brains
  4. Malaria elimination
  5. Chikungunya vaccine

  Ovarian Neoplasms

  Free Subscription


Articles published in Nat Med

Retrieve available abstracts of 6 articles:
HTML format



Single Articles


    January 2025
  1. CHRISTIANSEN F, Konuk E, Ganeshan AR, Welch R, et al
    International multicenter validation of AI-driven ultrasound detection of ovarian cancer.
    Nat Med. 2025 Jan 2. doi: 10.1038/s41591-024-03329.
    PubMed     Abstract available


    June 2024
  2. JIANG R, Feng Y, Chen Y, Cheng X, et al
    Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial.
    Nat Med. 2024 Jun 1. doi: 10.1038/s41591-024-02981.
    PubMed     Abstract available


    May 2024
  3. WU X, Liu J, Wang J, Wang L, et al
    Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial.
    Nat Med. 2024 May 15. doi: 10.1038/s41591-024-03003.
    PubMed     Abstract available


  4. FRIEDMAN CF, Manning-Geist BL, Zhou Q, Soumerai T, et al
    Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.
    Nat Med. 2024;30:1330-1338.
    PubMed     Abstract available


    January 2024
  5. AMGAD M, Hodge JM, Elsebaie MAT, Bodelon C, et al
    A population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer.
    Nat Med. 2024;30:85-97.
    PubMed     Abstract available


    June 2023
  6. YAP TA, Fontana E, Lee EK, Spigel DR, et al
    Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.
    Nat Med. 2023;29:1400-1411.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.